← Leaderboards
Mohamed E Labib
Novaflux Technologies, Inc.
$20,940,614
Attributed
$25,272,115
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,359,458 · 22
By mechanism
R44$18,334,914 · 8
U19$4,554,265 · 5
U18$2,130,641 · 1
R43$1,293,641 · 5
R33$1,264,187 · 1
R21$406,950 · 1
Top collaborators
- John William Costerton3 shared
- Seo Yean Sohn3 shared
- Paul Stoodley2 shared
- Sandeep Kathju1 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseDesignPreventSurfaceTechnologyInfectionLiquid SubstanceExcisionDevicesTransmission ProcessNew TechnologyMicrobial BiofilmsWaterProtocols DocumentationPrototypeChronicCostSuccessDialysis ProcedurePerformanceReportingSafetyComplexEnsure
Grant awards (49)
Novel hand hygiene product to remove Clostridioides difficile spores$993,963
R44 · FY2025 · AI · contact PI
Novel hand hygiene product to remove Clostridioides difficile spores$993,963
R44 · FY2024 · AI · contact PI
Novel hand hygiene product to remove Clostridioides difficile spores$993,963
R44 · FY2023 · AI · contact PI
Novel Implantable Device to Negate Post-Amputation Pain$2,130,641
U18 · FY2021 · EB · contact PI
Novel outside-in dialyzer with long filter life and reduced anticoagulation therapies$999,999
R44 · FY2021 · DK · contact PI
Novel outside-in dialyzer with long filter life and reduced anticoagulation therapies$999,999
R44 · FY2020 · DK · contact PI
Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$993,073
R44 · FY2020 · AI
Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$999,998
R44 · FY2019 · AI
Optimal channel and lever sampling of duodenoscopes for culture using portable Two-Phase Flow technology$300,000
R43 · FY2019 · AI · contact PI
Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$999,998
R44 · FY2018 · AI
Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics$999,999
R44 · FY2013 · DK · contact PI
Microbicide delivery system to target lymphoid organs$391,356
R33 · FY2013 · AI · contact PI
Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics$999,999
R44 · FY2012 · DK · contact PI
Microbicide delivery system to target lymphoid organs$430,882
R33 · FY2012 · AI · contact PI
Microbicide delivery system to target lymphoid organs$441,949
R33 · FY2011 · AI · contact PI
Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics$300,000
R44 · FY2011 · DK · contact PI
A Novel Device for Managing Hypervolemia in CHF Patients$299,989
R43 · FY2011 · HL · contact PI
Novel biofilm polymicrobial infection-resistant implants for otologic application$605,267
R44 · FY2010 · DC · contact PI
A Novel Device for Managing Hypervolemia in CHF Patients$299,989
R43 · FY2010 · HL · contact PI
Microbicide delivery system to target lymphoid organs$198,970
R21 · FY2010 · AI · contact PI
Novel biofilm polymicrobial infection-resistant implants for otologic application$634,028
R44 · FY2009 · DC · contact PI
Microbicide delivery system to target lymphoid organs$207,980
R21 · FY2009 · AI · contact PI
Novel Technology for Reprocessing Flexible Endoscopes$705,601
R44 · FY2008 · DK · contact PI
Improved Technology for Reprocessing Hemodialyzers$693,137
R44 · FY2008 · DK · contact PI
Novel Technology for Reprocessing Flexible Endoscopes$867,696
R44 · FY2007 · DK · contact PI
Improved Technology for Reprocessing Hemodialyzers$759,551
R44 · FY2007 · DK · contact PI
Single and multi-component biguanide-based microbicides$718,738
U19 · FY2007 · AI · contact PI
Modeling, synthesis, and preclinical formulation of biguanidines$502,564
U19 · FY2007 · AI · contact PI
Biofilm polymicrobial infection-resistant implants for otologic application$161,470
R43 · FY2007 · DC · contact PI
Single and multi-component biguanide-based microbicides$148,098
U19 · FY2007 · AI · contact PI
Novel Technology for Reprocessing Flexible Endoscopes$729,525
R44 · FY2006 · DK · contact PI
Single and multi-component biguanide-based microbicides$726,383
U19 · FY2006 · HD · contact PI
Improved Technology for Reprocessing Hemodialyzers$672,379
R44 · FY2006 · DK · contact PI
Modeling, synthesis, and formulation of biguanidines$305,394
U19 · FY2006 · HD · contact PI
Single and multi-component biguanide-based microbicides$743,952
U19 · FY2005 · HD
Low Temp Decontamination/Sterilize/Dental Handpieces$380,393
R44 · FY2005 · DE
Modeling, synthesis, and formulation of biguanidines$302,156
U19 · FY2005 · HD
Single and multi-component biguanide-based microbicides$750,172
U19 · FY2004 · HD
Low Temp Decontamination/Sterilize/Dental Handpieces$406,013
R44 · FY2004 · DE
Modeling, synthesis, and formulation of biguanidines$301,008
U19 · FY2004 · HD
Administrative Core$55,800
U19 · FY2004 · HD
Novel Technology for Reprocessing Flexible Endoscopes$308,951
R44 · FY2003 · DK
Novel Technology for Reprocessing Flexible Endoscopes$499,831
R44 · FY2002 · DK
Improved Technology for Reprocessing Hemodialyzers$407,080
R44 · FY2002 · DK
Improved Technology for Reprocessing Hemodialyzers$390,508
R44 · FY2001 · DK
CONTROL OF MICROBIAL BIOFILMS IN DENTAL UNIT WATERLINES$374,860
N44 · FY2000 · DE
NOVEL TECHNOLOGY FOR REPROCESSING FLEXIBLE ENDOSCOPES$132,193
R43 · FY2000 · DK
DECONTAMINATION /STERILIZATION OF DENTAL HANDPIECES$100,000
R43 · FY2000 · DE
CONTROL OF MICROBIAL BIOFILMS IN DENTAL UNIT WATERLINES$0
N44 · FY2000 · DE